Hun-Gyu Hwang

Dr. Hun-Gyu Hwang

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SBSoo-Mee Bang
Soo-Mee Bang
MJMoon Ju Jang
Moon Ju Jang
KKKyoung Ha Kim
Kyoung Ha Kim
HYHo-Young Yhim
Ho-Young Yhim
YKYeo-Kyeoung Kim
Yeo-Kyeoung Kim
DODoyeun Oh
Doyeun Oh
Bang SM, et al. J Korean Med Sci. 2014 Feb;29(2):164-171. https://doi.org/10.3346/jkms.2014.29.2.164

1 November 2015 in Lung Cancer
Verified
Journal Article
Closed access
MKMyung Shin Kim
Myung Shin Kim
EKEunsom Kim
Eunsom Kim
JHJeong-Seok Heo
Jeong-Seok Heo
DBDa-Jeong Bae
Da-Jeong Bae
JLJong-Uk Lee
Jong-Uk Lee
CPChoon-Sik Park
Choon-Sik Park

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HHHun-Gyu Hwang
Hun-Gyu Hwang
JLJu Hyun Lee
Ju Hyun Lee
SKSang-A Kim
Sang-A Kim
YKYang-Ki Kim
Yang-Ki Kim
HYHo-Young Yhim
Ho-Young Yhim
SBSoo-Mee Bang
Soo-Mee Bang
Hwang HG, et al. J Korean Med Sci. 2022 Apr;37(17):e130. https://doi.org/10.3346/jkms.2022.37.e130

1 January 2019 in Tuberculosis and Respiratory Diseases
Verified
Journal Article
Open access
PDF file
HHHun-Gyu Hwang
Hun-Gyu Hwang
WCWon-Il Choi
Won-Il Choi
BLBora Lee
Bora Lee
CLChoong Won Lee
Choong Won Lee
Hwang HG, et al. Tuberc Respir Dis. 2019 Feb;82:e16. https://doi.org/10.4046/trd.2019.0019

30 May 2017 in Respiratory Research
Verified
Journal Article
Open access
PDF file
JKJunghyun Kim
Junghyun Kim
WKWoo-Jin Kim
Woo-Jin Kim
CLChang-Hoon Lee
Chang-Hoon Lee
SLSang Haak Lee
Sang Haak Lee
MLMyung Goo Lee
Myung Goo Lee
KJKi Suck Jung
Ki Suck Jung
It is unclear whether various bronchodilator reversibility (BDR) criteria affect the prognosis of chronic obstructive pulmonary disease (COPD). The aim of this study is to evaluate the impact of positive BDR defined according to various BDR criteria on the risk of severe acute exacerbation (AE) in COPD patients. Patients from four prospective COPD cohorts in South Korea who underwent follow-up for at least 1 year were enrolled in this study. The assessed BDR criteria included the Global Initiative for Chronic Obstructive Lung Disease (GOLD), American Thoracic Society (ATS), American College of Chest Physicians, (ACCP), major criteria of the Spanish definition of asthma-COPD overlap syndrome (ACOS), criteria compatible with ACOS in the Global Initiative for Asthma (GINA), and European Respiratory Society (ERS). The rate of patients with severe AE who required hospitalization within 1 year due to BDR results according to each set of criteria was analyzed using logistic regression models. Among a total of 854 patients, the BDR-positive cases varied according to the criteria used. There was a 3.5% positive BDR rate according to GINA and a 29.9% rate according to the ATS criteria. Positive BDR according to the GOLD criteria was significantly associated with a decreased risk of severe AE (adjusted odds ratio (aOR) = 0.38; 95% Confidence interval (CI) = 0.15–0.93). This result remained statistically significant even in a sensitivity analysis that included only participants with a smoking history of at least 10 pack-years and in the analysis for the propensity score-matched participants. Among different criteria for positive BDR, the use of the GOLD ones was significantly associated with a decreased risk of severe AE in COPD patients. Increase use of ICS/LABA may have affected this relationship.

Verified
Journal Article
Open access
PDF file
YKYeon Wook Kim
Yeon Wook Kim
CLChang-Hoon Lee
Chang-Hoon Lee
HHHun-Gyu Hwang
Hun-Gyu Hwang
YKYu-Il Kim
Yu-Il Kim
DKDeog Kyeom Kim
Deog Kyeom Kim
SLSang-Do Lee
Sang-Do Lee
Background: Although a reduced carbon monoxide transfer coefficient (Kco) is an important feature in chronic obstructive pulmonary disease (COPD), how it changes over time and its relationship with other clinical outcomes remain unclear. This study evaluated longitudinal changes in Kco and their relationship with other clinical outcomes. Methods: We evaluated patients with COPD from the Korean Obstructive Lung Disease cohort, followed up for up to ten years. Random coefficient models were used to assess the annual change in Kco over time. Participants were categorized into tertiles according to Kco decline rate. Baseline characteristics and outcomes, including changes in FEV1 and emphysema index, incidence of exacerbations, and mortality, were compared between categories. Results: A decline in Kco was observed in 92.9% of the 211 enrolled participants with COPD. Those with the most rapid decline (tertile 1) had a lower FEV1/FVC% (tertile 1: 43.8% ± 9.7%, tertile 2: 46.4% ± 10.5%, tertile 3: 49.2% ± 10.4%, p = 0.008) and a higher emphysema index at baseline (27.7 ± 14.8, 22.4 ± 16.1, 18.1 ± 14.5, respectively, p = 0.001). Tertile 3 showed a lower decline rate in FEV1 (16.3 vs. 27.1 mL/yr, p = 0.017) and a lower incidence of exacerbations (incidence rate ratio = 0.66, 95% CI = 0.44–0.99) than tertile 1. There were no differences in the change in emphysema index and mortality between categories. Conclusion: Most patients with COPD experienced Kco decline over time, which was greater in patients with more severe airflow limitation and emphysema. Decline in Kco was associated with an accelerated decline in FEV1 and more frequent exacerbations; hence, this should be considered as an important outcome measure in further studies.